Structure Therapeutics (GPCR) just moved its obesity pipeline up a gear by kicking off a first in human Phase 1 trial for ACCG-2671, its oral amylin receptor agonist targeting metabolic disease. See ...
Scientists have developed a novel Cr-based single-atom catalyst that enables highly efficient hydrogen peroxide (H2O2) production in acidic environments through an electrochemical process. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback